工程化机械敏感间充质干细胞(MSCs)能够实现针对不同类型肿瘤的合成放射治疗与诊断双重靶向治疗。
Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types
Xiujie Yang, Qi Yin, Kui Li, Jianze Wang, Rui Song, Haoyi Zhou, Shu Han, Linyu Zhang, Yuwen Zeng, Da Xu, Feng Wang, Shixin Zhou, Yang Yang, Hua Zhu, Chunhong Zheng, Yang Li, Zhi Yang, Xing Yang, Zhao
Journal:Cell Stem Cell
IF:23.3
DOI:10.1016/j.stem.2026.07.015
PMID:42624106
Published:2026-08-20
research field:肿瘤学分子生物学细胞生物学
Abstract
Radiopharmaceutical-based imaging and targeted radionuclide therapy are often limited by heterogeneous or absent molecular targets in tumors. Here, we present a stiffness-responsive mesenchymal stem cell (MSC)-assisted relayed tumor-targeting (SMART) platform that converts matrix stiffness into a programmable molecular entry point for radiotheranostics. Engineered MSCs sense elevated mechanical stiffness within the tumor microenvironment and induce localized expression of synthetic biomarkers, thereby enabling radiopharmaceutical targeting independent of endogenous target availability. As a proof of concept, SMART-driven expression of prostate-specific membrane antigen (PSMA) enables sensitive tumor detection by 68 Ga-PSMA-617 positron emission tomography (PET) and effective treatment with 177 Lu-AB-PSMA-617 across multiple tumor models, with improved sensitivity and reduced off-target uptake compared with conventional 18 F-fluorodeoxyglucose PET. This platform is readily adaptable to alternative synthetic targets and induced pluripotent stem cell (iPSC)-derived MSCs. By translating a universal physical feature of tumors into an actionable molecular signature, SMART expands the scope of precision radiotheranostics beyond native biomarkers.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


